Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles

Rolosense:用于自动手机读取活性 SARS-CoV-2 颗粒的创新平台

基本信息

  • 批准号:
    10264612
  • 负责人:
  • 金额:
    $ 44.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-21 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

Project Abstract The ultimate goal of this proposal is to develop a novel platform technology for automatic surveillance and tracing of airborne SARS-CoV-2 virus particles in real time. The centerpiece of this proposal is the “Rolosense” technology which leverages a DNA micromotor as the virus sensing and transduction material (VSTM) that can be detected by a conventional smart phone camera. This provides both geographical tracing and surveillance. Rolosense motor are comprised a DNA-coated spherical particle (5 micrometer diameter) that hybridizes to a surface modified with complementary RNA. The particle moves at speeds of over 1 micron/minute upon the addition of RNase H, which selectively hydrolyses hybridized RNA but not single-stranded RNA. DNA motors coated with virus binding ligand (VBL) stall in presence of SARS-CoV-2 virus particles. Because motors move autonomously for distances up to millimeters without intervention, the assay is fully automated, and conventional steps such as viral inactivation, RNA isolation and amplification are not required. The readout is performed using an automated smart phone app for particle tracking without the need for a spectrophotometer or fluorometer. Preliminary data shows realtime SARS-CoV-2 pseudovirus particle sensing. Milestones include the screening and identification of high affinity and high specificity VBLs. Both aptamers and antibody VBLs will be screening and validated. Simulations and experiments will be used to understand the role of temperature and environmental conditions in modulating Rolosense performance. Multivalent display of VBLs with DNA origami will enhance avidity. Finally, microfluidic chips with airborne droplet capture will be implemented and tested. The work will be performed by a highly interdisciplinary team with complementary expertise and a track-record of co-publications. PI Salaita invented the Rolosense technology and has past experience in developing cell phone diagnostics and synthetic motors. Co-I Melikian is an expert virologist, Co-I Heemstra is an expert at developing aptamers for novel targets, Co-I Ke has extensive experience in DNA origami structures for avid target binding and has co-authored work on Rolosense, Co-I Rajaraman and Primordia are experts at microfluidic device development and commercialization. Our solution offers the potential to provide an immediate solution to today’s urgent virus sensing and tracing needs.
项目摘要 这项提议的最终目标是开发一种新的自动监控平台技术 以及空气传播的SARS-CoV-2病毒颗粒的实时跟踪。这项提案的核心是 利用DNA微马达作为病毒传感和转导的“Rolosense”技术 传统智能手机摄像头可以检测到的材料(VSTM)。这既提供了 地理追踪和监视。劳斯莱斯马达由一个包裹着DNA的球形颗粒组成 (直径5微米)与互补RNA修饰的表面杂交。粒子 添加核糖核酸酶H后,移动速度超过1微米/分钟,核糖核酸酶H选择性地水解 杂化的RNA,但不是单链RNA。涂有病毒结合配体(VBL)的DNA马达 在存在SARS-CoV-2病毒颗粒的情况下。因为马达自动移动的距离可达 毫米,无需干预,检测是完全自动化的,常规步骤,如病毒 不需要灭活、RNA分离和扩增。读出是使用 自动智能手机应用程序,无需分光光度计或 荧光计。初步数据显示,SARS-CoV-2伪病毒粒子实时检测。里程碑 包括高亲和力和高特异性VBL的筛选和鉴定。适配子和适体 将对抗体VBL进行筛选和验证。模拟和实验将被用来理解 温度和环境条件在调节罗氏性能中的作用。 用DNA折纸多价展示VBL将增强亲和力。最后,微流控芯片具有 将实施和测试空中液滴捕获。这项工作将由一位高度 具有互补专业知识和联合出版记录的跨学科团队。皮萨莱塔 发明了Rolosense技术,并且过去有开发手机诊断和 合成马达。Co-I Melikian是病毒学家,Co-I Heemstra是研究 新靶标的适体,Co-i Ke在DNA折纸结构方面具有丰富的经验,可用于狂热的靶标 BINGING并与人合著了Rolosense,Co-I Rajaraman和Primordia是 微流控器件的开发和商业化。我们的解决方案提供了提供 立即解决当今紧迫的病毒检测和跟踪需求。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Khalid S Salaita其他文献

Khalid S Salaita的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Khalid S Salaita', 18)}}的其他基金

Center on Probes for Molecular Mechanotechnology
分子机械技术探针中心
  • 批准号:
    10629919
  • 财政年份:
    2023
  • 资助金额:
    $ 44.97万
  • 项目类别:
Mechano-ID for tagging immune cells
用于标记免疫细胞的 Mechano-ID
  • 批准号:
    10608815
  • 财政年份:
    2022
  • 资助金额:
    $ 44.97万
  • 项目类别:
Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles (RADx-rad / SEED Administrative Supplement)
Rolosense:用于自动手机读取活性 SARS-CoV-2 颗粒的创新平台(RADx-rad / SEED 行政补充文件)
  • 批准号:
    10648924
  • 财政年份:
    2022
  • 资助金额:
    $ 44.97万
  • 项目类别:
Mechano-ID for tagging immune cells
用于标记免疫细胞的 Mechano-ID
  • 批准号:
    10664365
  • 财政年份:
    2022
  • 资助金额:
    $ 44.97万
  • 项目类别:
Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles
Rolosense:用于自动手机读取活性 SARS-CoV-2 颗粒的创新平台
  • 批准号:
    10321002
  • 财政年份:
    2020
  • 资助金额:
    $ 44.97万
  • 项目类别:
Catalytic Nanotherapies to Treat Lung Disease
治疗肺部疾病的催化纳米疗法
  • 批准号:
    9977246
  • 财政年份:
    2018
  • 资助金额:
    $ 44.97万
  • 项目类别:
Catalytic Nanotherapies to Treat Lung Disease
治疗肺部疾病的催化纳米疗法
  • 批准号:
    10169812
  • 财政年份:
    2018
  • 资助金额:
    $ 44.97万
  • 项目类别:
Catalytic Nanotherapies to Treat Lung Disease
治疗肺部疾病的催化纳米疗法
  • 批准号:
    10227119
  • 财政年份:
    2018
  • 资助金额:
    $ 44.97万
  • 项目类别:
Catalytic Nanotherapies to Treat Lung Disease
治疗肺部疾病的催化纳米疗法
  • 批准号:
    10463234
  • 财政年份:
    2018
  • 资助金额:
    $ 44.97万
  • 项目类别:
Developing a Bioanalytical Toolkit to Study the Mechanobiology of Juxtacrine Signaling
开发生物分析工具包来研究近分泌信号传导的力学生物学
  • 批准号:
    9894683
  • 财政年份:
    2017
  • 资助金额:
    $ 44.97万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.97万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.97万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.97万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 44.97万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 44.97万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 44.97万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 44.97万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 44.97万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 44.97万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 44.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了